119 related articles for article (PubMed ID: 10924575)
1. Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy.
Abramson RG; Rosen MP; Perry LJ; Brophy DP; Raeburn SL; Stuart KE
Radiology; 2000 Aug; 216(2):485-91. PubMed ID: 10924575
[TBL] [Abstract][Full Text] [Related]
2. Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial.
Sanz-Altamira PM; Spence LD; Huberman MS; Posner MR; Steele G; Perry LJ; Stuart KE
Dis Colon Rectum; 1997 Jul; 40(7):770-5. PubMed ID: 9221850
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
Rostambeigi N; Dekarske AS; Austin EE; Golzarian J; Cressman EN
J Vasc Interv Radiol; 2014 Jul; 25(7):1075-84. PubMed ID: 24861664
[TBL] [Abstract][Full Text] [Related]
4. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors.
Gupta S; Bedikian AY; Ahrar J; Ensor J; Ahrar K; Madoff DC; Wallace MJ; Murthy R; Tam A; Hwu P
Am J Clin Oncol; 2010 Oct; 33(5):474-80. PubMed ID: 19935383
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases.
Durand-Zaleski I; Earlam S; Fordy C; Davies M; Allen-Mersh TG
Cancer; 1998 Sep; 83(5):882-8. PubMed ID: 9731890
[TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study.
Maire F; Lombard-Bohas C; O'Toole D; Vullierme MP; Rebours V; Couvelard A; Pelletier AL; Zappa M; Pilleul F; Hentic O; Hammel P; Ruszniewski P
Neuroendocrinology; 2012; 96(4):294-300. PubMed ID: 22507901
[TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms.
Shetty SK; Rosen MP; Raptopoulos V; Goldberg SN
J Vasc Interv Radiol; 2001 Jul; 12(7):823-33. PubMed ID: 11435538
[TBL] [Abstract][Full Text] [Related]
9. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of intermittent hepatic arterial infusion chemotherapy for multiple liver metastasis of colorectal cancer].
Yoshioka S; Morimoto T; Shingai T; Azama T; Katsumoto Y; Nakaguchi K; Furukawa J; Okajima S; Sue F
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1721-4. PubMed ID: 10560380
[TBL] [Abstract][Full Text] [Related]
11. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
12. [Clinical outcome of intra-hepatic arterial infusion therapy for multiple liver metastases from colorectal cancer].
Okamoto N; Maruta M; Maeda K; Sato H; Takizawa K; Masumori K; Aoyama H; Kato R
Gan To Kagaku Ryoho; 2003 Apr; 30(4):501-4. PubMed ID: 12722681
[TBL] [Abstract][Full Text] [Related]
13. [Weekly hepatic arterial infusion of high dose 5-fluorouracil for liver metastasis from colorectal cancer].
Takizawa K; Maruta M; Maeda K; Utsumi T; Masumori K; Matsumoto M; Koide Y; Aoyama H; Senda K; Ishihara O; Matsuoka H
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1718-20. PubMed ID: 10560379
[TBL] [Abstract][Full Text] [Related]
14. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.
Gazelle GS; McMahon PM; Beinfeld MT; Halpern EF; Weinstein MC
Radiology; 2004 Dec; 233(3):729-39. PubMed ID: 15564408
[TBL] [Abstract][Full Text] [Related]
15. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors.
Kobayashi K; Gupta S; Trent JC; Vauthey JN; Krishnamurthy S; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; McRae SE; Hicks ME
Cancer; 2006 Dec; 107(12):2833-41. PubMed ID: 17096432
[TBL] [Abstract][Full Text] [Related]
16. [Continuous hepatic artery infusion chemotherapy and chemoembolization for treatment of patients with liver metastases from colorectal cancer].
Zhao Y; Wang SM; Zhang J
Ai Zheng; 2002 Apr; 21(4):421-3. PubMed ID: 12452025
[TBL] [Abstract][Full Text] [Related]
17. Innovative chemotherapies for stage III colon cancer: a cost-effectiveness study.
Koperna T; Semmler D
Hepatogastroenterology; 2003; 50(54):1903-9. PubMed ID: 14696430
[TBL] [Abstract][Full Text] [Related]
18. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
Yan TD; Padang R; Morris DL
J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
[TBL] [Abstract][Full Text] [Related]
19. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma.
Ahrar J; Gupta S; Ensor J; Ahrar K; Madoff DC; Wallace MJ; Murthy R; Tam A; Hwu P; Bedikian AY
Cancer Invest; 2011 Jan; 29(1):49-55. PubMed ID: 21166498
[TBL] [Abstract][Full Text] [Related]
20. Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis.
Beard SM; Holmes M; Price C; Majeed AW
Ann Surg; 2000 Dec; 232(6):763-76. PubMed ID: 11088071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
